CureSight

NovaSight eyes FDA clearance with upcoming clinical trial
By Mallory Hackett | 01:18 pm | March 16, 2021
The company’s digital therapy CureSight presents a new treatment method for amblyopia, also known as lazy eye, that doesn’t require patching.